Want to see FR:FII full AI Analyst Report?
FII Stock Chart & Stats
€66.90
-€0.20(-0.30%)
At close: 4:00 PM EDT
€66.90
-€0.20(-0.30%)
Day’s Range― - ―
52-Week Range€37.55 - €72.60
Previous CloseN/A
Volume35.34K
Average Volume (3M)33.39K
Market Cap
€2.88B
Enterprise Value€3.34K
Total Cash (Recent Filing)€246.76M
Total Debt (Recent Filing)€511.81M
Price to Earnings (P/E)17.7
Beta0.91
Next Earnings
Feb 18, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.73%
Share Statistics
EPS (TTM)3.58
Shares Outstanding46,538,315
10 Day Avg. Volume24,786
30 Day Avg. Volume33,391
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)2.23
Price to Sales (P/S)1.39
P/FCF Ratio32.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.78
Revenue Forecast (FY)€1.92B
Bulls Say, Bears Say
Bulls Say
Aerospace High-performance FastenersLISI’s aerospace franchise supplies certified, safety-critical fasteners that require lengthy qualification and traceability. These barriers to entry create durable customer stickiness, recurring program revenue and higher-value product mix that supports stable long-term margins and program-level pricing power.
Improved LeverageDebt falling to under 50% of equity materially improves balance-sheet flexibility, reducing refinancing and liquidity risk across cycles. This positions the company to invest in tooling, pursue platform awards, and endure temporary revenue dips without immediate capital raises, supporting durable operations.
Solid Operating Profitability And ROERecovery to mid-single-digit operating margins and a ~13% ROE indicates the business can generate acceptable returns on capital when volumes align. Sustainable profitability at these levels enables reinvestment in engineering and capacity to defend program positions versus pure commodity competitors.
Bears Say
2025 Revenue DeclineA near-term revenue drop of ~6.7% after several years of expansion signals sensitivity to end-market production and program timing. Structural exposure to aerospace and auto build rates means revenue can reverse quickly if OEM production or platform awards slow, challenging medium-term growth visibility.
Volatile MarginsMaterial year-to-year margin swings reduce predictability of earnings and weaken confidence in sustained cash generation. Volatility likely stems from mix, program ramp timing and input-cost pass-through limits, which can amplify cyclical earnings declines and pressure leverage in downturns.
Moderate Cash ConversionOperating cash flow and FCF trailing net income, with FCF under half of earnings, indicates working-capital needs or capex absorb cash. Limited cash conversion constrains the company’s ability to self-fund growth, pay higher distributions, or pursue M&A without increasing leverage or external financing.
Lisi SA News
FII FAQ
What was Lisi SA’s price range in the past 12 months?
Lisi SA lowest stock price was €37.55 and its highest was €72.60 in the past 12 months.
What is Lisi SA’s market cap?
Lisi SA’s market cap is €2.88B.
When is Lisi SA’s upcoming earnings report date?
Lisi SA’s upcoming earnings report date is Feb 18, 2027 which is in 200 days.
How were Lisi SA’s earnings last quarter?
Lisi SA released its earnings results on Jul 23, 2026. The company reported €1.358 earnings per share for the quarter, beating the consensus estimate of N/A by €1.358.
Is Lisi SA overvalued?
According to Wall Street analysts Lisi SA’s price is currently Overvalued.
Does Lisi SA pay dividends?
Lisi SA pays a Annually dividend of €0.46 which represents an annual dividend yield of 0.73%. See more information on Lisi SA dividends here
What is Lisi SA’s EPS estimate?
Lisi SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lisi SA have?
Lisi SA has 46,538,315 shares outstanding.
What happened to Lisi SA’s price movement after its last earnings report?
Lisi SA reported an EPS of €1.358 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.189%.
Which hedge fund is a major shareholder of Lisi SA?
Currently, no hedge funds are holding shares in FR:FII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lisi SA
Lisi S.A. is a global provider of specialized assembly and component solutions, primarily serving the aerospace, automotive, and medical sectors. The company organizes its operations into three distinct divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace specializes in advanced aircraft components, including titanium fasteners, lightning protection, safety locking mechanisms, and fuse pins. Their contributions to the LEAP engine encompass compressor blades, struts, and composite fan blade leading edges. They also produce air intake lipskins for Airbus aircraft, semi-machined gears for power transmission, stator vanes, and satellite antenna mounting brackets for both airplanes and helicopters. LISI Automotive delivers a broad spectrum of fastening and component solutions for vehicles. This includes guide pins, electric parking brake elements, complete braking systems, and direct engine injection parts. They supply various fasteners like screws, nuts, and specialized clips for interior and exterior trim, alongside components for seat belt mechanisms, motor systems, and safety applications. The division also focuses on assembly optimization, offering cable ducts, battery fastening systems, intricate power transmission parts, and standard automotive fasteners. Furthermore, they provide clipped fastening solutions for both internal and external cladding, specialized fasteners for tubes and cables, and products designed to reduce weight and streamline assembly processes. Their portfolio extends to critical components for braking, fluid management, seat adjustment, and interior safety systems. LISI Medical is involved in the complete lifecycle of medical device development, from initial design and modeling through prototyping, pre-series production, material selection, process validation, and inventory management. They manufacture a range of orthopedic reconstruction implants for shoulders, hips, knees, and extremities, along with associated surgical instruments. The division also produces various surgical tools, such as blades, scissors, staplers, and pliers. Additionally, they provide spinal and trauma implants, including connectors, screws, cages, plates, and prostheses, specifically designed for treating trauma and facilitating osteosynthesis. Established in 1777, the company, originally known as GFI Industries, adopted the name LISI S.A. in 2002. Headquartered in Belfort, France, it operates as a subsidiary of Compagnie Industrielle De Delle S.A.